Therapy Areas: Respiratory
Novartis to build new radioligand therapy site in Texas
...
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, ...
Epredia signs EU distribution deal with Mindpeak for AI pathology software
24 February 2026 - Precision cancer diagnostics specialist Epredia, a subsidiary of PHC Holdings Corporation (TSE:6523), and Mindpeak, a provider of AI solutions for clinical and research pathology, o...
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
...
CStone Pharmaceuticals' sugemalimab granted new indication by UK MHRA
23 February 2026 - Chinese biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) announced on Sunday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new ind...
Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons
19 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Thursday reported positive second-season results from the Phase 3 SMART trial eva...